Form 4: Bioventus Inc. Director William A. Hawkins Reports Stock Transaction
SEC Form 4 Filing
Director William A. Hawkins reports the vesting and conversion of restricted stock units into Class A Common Stock of Bioventus Inc.
Summary
- On June 7, 2024, William A. Hawkins, a director of Bioventus Inc., had 30,400 restricted stock units (RSUs) vest.
- These RSUs were converted into 30,400 shares of Class A Common Stock.
- The transaction did not involve any monetary exchange, as the price is listed as $0.
- Following the transaction, Hawkins directly owns 231,358 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 06/07/2024 | Date of transaction: vesting of restricted stock units and conversion to Class A Common Stock. |
| 06/11/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.